Clinical trial
Safety of the EnvPro HIV Vaccine in Healthy Volunteers
NCT00076947 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00076947 |
|---|---|
| Title | Safety of the EnvPro HIV Vaccine in Healthy Volunteers |
| Official title | Evaluation of Tolerability and Safety of a Recombinant Purified HIV Envelope Vaccine |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | EnvPro |
| Enrollment | 10 |
| Start date | Aug 1, 2003 |
| First posted | Feb 9, 2004 |
| Last update posted | Mar 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: